Concanavalin A (Con A) and phytohemagglutinin (PHA) released histamine from hamster mast cells incubated in a serum-free medium. Concentrations of Con A and PHA approximating those optimal for transforming lymphocytes also released maximal amounts of histamine without apparent cvtotoxicity. Higher concentrations of mitogen inhibited both lymphocyte transformation and histamine release. Incubation at 37 C for 15 min released histamine, although longer times were more effective. Supernatants from cultured hamster splenocytes stimulated with Con A also released histamine from added mast cells. However, the effect could be inhibited by the addition of 0.1 M methyl alpha-D-mannoside or by passing the spleen cell culture supernatants through Sephadex G-75 to remove Cbn A. This mitogen-induced release of mast cell histamine is therefore not mediated by a lymphokine but probably results from a direct interaction of mitogens with receptors on mast cells.
Mast cells release histamine and other pharmacologically active substances into surrounding tissues upon alteration of the mast cell surface. Hamster mast cells release histamine upon exposure to a variety of biological and chemical agents including polypeptides isolated from granulocytes, compound 48/80, and mellitin (7) . In immediate hypersensitivity reactions, histamine is secreted subsequent to the reaction of allergen with reaginic antibody on the surface of the cells (1, 5) . It was recently reported by Keller (6) that mast cells obtained from rats sensitized with the nematode Nippostrongylus brasiliensis, but not those from normal rats, rapidly released histamine when triggered by concanavalin A (Con A).
We have tested the lectins Con A and phytohemagglutinin (PHA), which are mitogenic for lymphocytes (10, 13) , and have found that they also release histamine from mast cells collected from nonimmunized hamsters. The mechanism of release by these lectins was studied because this provides another probe for investigating the process of histamine secretion.
MATERIALS AND METHODS Preparation of cell suspensions. Female, 10-to 12-week-old hamsters (LVG: LAK) were purchased from Lakeview Hamster Colony, Newfield, N.J. For one experiment, virus-and parasite-free animals of the same age and strain were tested. Peritoneal mast cells were collected, as described previously, from the unstimulated abdominal washings of normal hamsters and washed three times with Veronal-buffered saline containing 0.1% gelatin and 2 U of heparin per ml (3) . After the final centrifugation at 150 x g, cells were pooled from three or more animals and suspended to twice the original volume in medium RPMI 1640 containing 0.0001% Ca(NO3)2 4H20 but without MgSO4 and phenol red. Molten gelatin was added to a final concentration of 0.1%, and the modified medium, designated 1640-G, was used as diluent for all experiments unless specified otherwise. The cell suspensions consisted of approximately 10% mast cells and the remainder consisted of polymorphonuclear and other types of leukocytes. Purified mast cells were obtained where specified by differential centrifugation at 330 x g into 30, 40, and 50% Ficoll layers as described by Uvnas and Thon (16) . The resulting mast cell pellet was resuspended to one-tenth the original cell volume in 1640-G medium and was found by phase-contrast microscopy to contain >90% mast cells.
Reaction mixtures. Suspensions containing 5 x 104 hamster mast cells in I ml were added in triplicate to plastic tubes (no. 2058; 12 by 75 mm; Falcon Plastics, Oxnard, Calif.). Cells were exposed to 0.1-ml volumes containing appropriate amounts of mitogens. These were: 5 gg of Con A (Calbiochem, San Diego, incubated with loose-fitting caps in an humidified atmosphere of 5% CO2 in air. After incubation, cells were pelleted by centrifugation at 500 x g for 15 (2) .
Inhibition of histamine release. Where specified, Con A or PHA was incubated with mast cells at 0 or 20 C for 1 h rather than at 37 C, or incubated in the presence of 0.1 M methyl alpha-D-mannoside (MAM), (Sigma Chemical Co., St. Louis, Mo.) or with the immunoglobulin G fraction of rabbit antiserum to Con A (kindly provided by Bruce Mackler and Robert Kelly, Kennedy Inst. of Rheumatology, London, England). This antiserum was prepared by adsorbing Con A to autologous rabbit erythrocytes and injecting the mixture intravenously four times at 3-to 4-week intervals. Supernatants from Con A-stimulated spleen cell cultures were freed of Con A by passing 2-ml volumes of the supernatants through columns (1 by 25 cm) of Sephadex G-75 (Pharmacia, Piscataway, N.J.). The eluent used was 0.85% NaCl. The removal of Con A from the eluate was determined from decreased optical density measurements at 280 nm, disappearance of Con A-induced agglutination of red blood cells, and reduction in the mitogenic effects of supernatants on hamster lymphocytes.
Histamine assay. Histamine was measured fluorometrically by the method of Lichtenstein (8) 
RESULTS
Hamster mast cells were incubated in the presence of a variety of mitogens and antigens at concentrations of 1 to 200 ug/ml. Optimal histamine release was obtained with 1 to 5 jig of Con A and 2.5 to 10 jig of PHA/ml (Fig. 1) . A similar dose response was obtained with cells obtained from virus-and parasite-free hamsters of the same strain and age. Increasing the concentration of Con A or PHA to 50 Ajg/ml or more inhibited histamine release. At higher concentrations of Con A or PHA (> 10 ,ug/ml), the uptake of tritiated thymidine by cultured splenic lymphocytes was also inhibited significantly. The histamine release and lymphocyte transformation response to multiple doses of a variety of mitogens and antigens were tested. Con A, indicating that binding by Con A did not occur at these lowered temperatures. Con A and PHA differed in their ability to adsorb to mast cells at 0 or 25 C. A 12 and 15% release was seen when mast cells were exposed to PHA ( Table 3 ), suggesting that PHA binds mast cells with greater activity than Con A. Rapid freezing and thawing, six times, of both Con A and PHA did not destroy their ability to release histamine. Addition of antiserum to Con A or of MAM, a competitive inhibitor of Con A, markedly inhibited Con A activity, but PHA inhibited only to a limited extent (Table 3) . DISCUSSION A variety of agents can induce histamine release from mast cells by different mechanisms. For example, a cationic protein from neutrophil lysosomes initiates distinct steps of intracellular activation and nonlytic release of histamine (14) . In the case of reaginic (immunoglobulin E [IgE ]) antibody, the release of histamine from rat mast cells can also be separated into two or more steps: sensitization of basophils with antibody, followed by challenge with antigen, resulting in the secretion of histamine (1) . There are other antibody-mediated reactions not involving reagins, in which histamine secretion occurs if mast cells are exposed to the cleavage products of the third (C3a) or fifth (C5a) components of complement that are generated by immune aggregates (13) . Hamster serum incubated with bacterial endotoxin will also generate a substance of approximately 60,000 molecular weight which will release histamine from hamster mast cells (4) . In contrast, the polypeptide mellitin from bee venom (17) and substances such as detergents release histamine by direct lysis.
Suspensions containing washed mast cells and other leukocytes from the unstimulated hamster peritoneum released a significant amount of histamine when incubated with the lectins Con A or PHA. Histamine release occurred with doses of Con A and PHA that were similar to the amount that stimulated hamster lymphocytes to incorporate [3H ]thymidine, as seen in this work and that described previously by Singh and Tevethia (15) . Since lymphocyte activation involves the interaction of stimulants with cell surface receptors, this suggests that an analogous reaction may be occuring between receptors on the mast cells and the mitogens involved in histamine release. The ability of mitogens to act as histamine-releasing agents, as observed in our work, is due to nonlytic mechanism since excess Con A or PHA failed to release histamine. Furthermore, microscope and 5'Cr-release studies of mast cells incubated in the presence of Con A also indicated that this lectin was not cytolytic at the histamine-releasing doses tested.
The possibility that histamine release by mast cells was due to a mitogen-induced lymphokine was tested. Indeed, supernatants ob- Our findings favor the view that the lectins interact directly with receptors on the surface of hamster mast cells. All the pooled cell populations from our "normal" immunized hamsters were reactive. Furthermore, work in progress shows that pooled cells from 9-to 10-weekold, virus-and parasite-free hamsters also released histamine in response to Con A. However, we can not exclude the possibility that "normal" hamsters have considerable amounts of IgE on their surface.
There is evidence from other laboratories favoring the view that lectin-induced histamine release is based on its interaction with the carbohydrate component on the Fc region of IgE. Keller has reported that mast cells from rats sensitized with N. brasiliensis released 18 to 24% of the available histamine within 2 to 10 min of incubation with 10 Brodsky, and R. P. Siraganian, J. Immunol., in press) that sensitivity of human basophils to histamine release by Con A correlated directly with sensitivity of cells to antiserum toward IgE, indicating that receptors for Con A were associated with IgE. We are currently testing this hypothesis by assaying the histamine release of hamsters that have been stimulated to produce "IgE" in response to immunization.
